This list is based on the watchlists of people on Stock Events who follow BIOSGN-BTA.ST. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Biosergen AB is a biopharmaceutical company specializing in the creation of antifungal medications. Its key development initiative is BSG005, an experimental antifungal drug candidate engineered to treat critical invasive fungal infections. The firm was established in 2004 and operates from its headquarters located in Solna, Sweden.
Show more...
FAQ
What is Biosergen AB stock price today?▼
The current price of BIOSGN-BTA.ST is SEK0.56 SEK — it has decreased by -1.77% in the past 24 hours. Watch Biosergen AB stock price performance more closely on the chart.
What is Biosergen AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Biosergen AB stocks are traded under the ticker BIOSGN-BTA.ST.
What is Biosergen AB market cap?▼
Today Biosergen AB has the market capitalization of 1.3M
When is the next Biosergen AB earnings date?▼
Biosergen AB is going to release the next earnings report on November 18, 2026.
What is Biosergen AB revenue for the last year?▼
Biosergen AB revenue for the last year amounts to 0 SEK.
What is Biosergen AB net income for the last year?▼
BIOSGN-BTA.ST net income for the last year is -38.01M SEK.
How many employees does Biosergen AB have?▼
As of September 04, 2026, the company has 1 employees.
In which sector is Biosergen AB located?▼
Biosergen AB operates in the Health & Wellness sector.
When did Biosergen AB complete a stock split?▼
Biosergen AB has not had any recent stock splits.
Where is Biosergen AB headquartered?▼
Biosergen AB is headquartered in Solna, Sweden.